{"date":"2026-04-22","count":39,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6541-2026-04-22-1952-jheyty","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-04-22","time":"19:52:31","subject":"代重要子公司台灣泰福生技股份有限公司公告董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-04-22 19:52，「代重要子公司台灣泰福生技股份有限公司公告董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-04-22-1951-kab96l","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-04-22","time":"19:51:40","subject":"公告本公司董事會決議召開115年股東常會(增列議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-04-22 19:51，「公告本公司董事會決議召開115年股東常會(增列議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-04-22-1950-1b20vj","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-04-22","time":"19:50:51","subject":"依「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款公告申報","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-04-22 19:50，「依「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款公告申報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-04-22-1944-1hr6s6j","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-04-22","time":"19:44:44","subject":"公告本公司董事會決議私募方式辦理現金增資發行普通股及/或私募國內或海外無擔保可轉換公司債案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-04-22 19:44，「公告本公司董事會決議私募方式辦理現金增資發行普通股及/或私募國內或海外無擔保可轉換公司債案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-04-22-1824-1tpjosz","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"18:24:14","subject":"公告本公司法人董事代表人辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-04-22 18:24，「公告本公司法人董事代表人辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-04-22-1823-1e71l3n","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"18:23:37","subject":"公告本公司董事長退休","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-04-22 18:23，「公告本公司董事長退休」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-04-22-1802-7qunhr","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"18:02:07","subject":"代重要子公司潤雅生技股份有限公司公告法人董事代表人辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-04-22 18:02，「代重要子公司潤雅生技股份有限公司公告法人董事代表人辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-04-22-1801-mc1vt9","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"18:01:46","subject":"代重要子公司潤雅生技股份有限公司公告董事長暨總經理退休","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-04-22 18:01，「代重要子公司潤雅生技股份有限公司公告董事長暨總經理退休」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-04-22-1801-1tpjosz","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"18:01:26","subject":"公告本公司法人董事代表人辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-04-22 18:01，「公告本公司法人董事代表人辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-04-22-1801-1vhu1xi","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"18:01:02","subject":"公告本公司發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-04-22 18:01，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-04-22-1800-1t4j9jj","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"18:00:38","subject":"公告本公司執行長(總經理)退休","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-04-22 18:00，「公告本公司執行長(總經理)退休」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-04-22-1733-7hadjo","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"17:33:00","subject":"代子公司「牧騰生物科技股份有限公司」公告向關係人取得使用權資產","clause":"第17款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-04-22 17:33，「代子公司「牧騰生物科技股份有限公司」公告向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-04-22-1728-1q9ilwa","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-04-22","time":"17:28:34","subject":"更正公告本公司股票初次上市現金增資競價拍賣及公開申購代收股款機構","clause":"第44款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-04-22 17:28，「更正公告本公司股票初次上市現金增資競價拍賣及公開申購代收股款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-04-22-1653-h4aiz1","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"16:53:17","subject":"公告本公司115年股東常會召集事由(修正承認事項)","clause":"第32款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-04-22 16:53，「公告本公司115年股東常會召集事由(修正承認事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-04-22-1651-1u5orhi","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"16:51:01","subject":"公告115年第一季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-04-22 16:51，「公告115年第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-04-22-1649-109jtcw","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"16:49:49","subject":"本公司受邀參加元大證券舉辦之線上法說會","clause":"第12款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-04-22 16:49，「本公司受邀參加元大證券舉辦之線上法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-04-22-1633-1xex3ef","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"16:33:19","subject":"公告本公司取得日本人工敷料製造方法發明專利核准通知。","clause":"第44款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-04-22 16:33，「公告本公司取得日本人工敷料製造方法發明專利核准通知。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-04-22-1626-becgzr","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"16:26:18","subject":"公告本公司115年股東常會召集事由之承認事項修正","clause":"第32款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-04-22 16:26，「公告本公司115年股東常會召集事由之承認事項修正」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-04-22-1624-isqttc","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"16:24:02","subject":"公告本公司董事會重要決議事項","clause":"第44款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-04-22 16:24，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-04-22-1603-p2ym0p","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"16:03:43","subject":"公告本公司將受邀參加富邦證券之法說會訊息","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-04-22 16:03，「公告本公司將受邀參加富邦證券之法說會訊息」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-04-22-1603-sbwufv","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"16:03:00","subject":"公告本公司舉辦115年第一次線上法說會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-04-22 16:03，「公告本公司舉辦115年第一次線上法說會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-04-22-1602-198290h","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-04-22","time":"16:02:22","subject":"本公司董事會決議辦理私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-04-22 16:02，「本公司董事會決議辦理私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-04-22-1600-1glpiyk","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"16:00:34","subject":"公告本公司股東會決議解除董事競業限制","clause":"第21款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-04-22 16:00，「公告本公司股東會決議解除董事競業限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-04-22-1559-5j9yh6","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"15:59:10","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-04-22 15:59，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-04-22-1558-jflio5","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"15:58:23","subject":"公告本公司115年股東會重要決議事項","clause":"第18款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-04-22 15:58，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-04-22-1558-1u3g5lo","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-04-22","time":"15:58:05","subject":"公告本公司受邀參加凱基證券舉辦之2026逆齡產業新賽道研討會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-04-22 15:58，「公告本公司受邀參加凱基證券舉辦之2026逆齡產業新賽道研討會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-04-22-1554-qdzk25","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-04-22","time":"15:54:15","subject":"公告本公司董事會決議115年股東常會召開事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-04-22 15:54，「公告本公司董事會決議115年股東常會召開事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2026-04-22-1553-1xubi2y","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"15:53:13","subject":"公告本公司因會計師事務所內部組織調整更換簽證會計師。","clause":"第7款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2026-04-22 15:53，「公告本公司因會計師事務所內部組織調整更換簽證會計師。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2026-04-22-1550-100x4ao","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"15:50:45","subject":"本公司董事會決議不分配股利","clause":"第31款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2026-04-22 15:50，「本公司董事會決議不分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2026-04-22-1544-1nb8hvk","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"15:44:16","subject":"公告本公司董事會決議通過114年度合併財務報告","clause":"第43款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2026-04-22 15:44，「公告本公司董事會決議通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-04-22-1532-qwuk1f","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-04-22","time":"15:32:30","subject":"公告本公司董事會決議召開115年股東會相關事宜(增列報告事項)","clause":"第17款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-04-22 15:32，「公告本公司董事會決議召開115年股東會相關事宜(增列報告事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-04-22-1531-uutmnv","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-04-22","time":"15:31:19","subject":"公告本公司稽核主管異動","clause":"第8款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-04-22 15:31，「公告本公司稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-04-22-1511-bwopfv","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"15:11:55","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-04-22 15:11，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-04-22-1502-pn3k2w","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"15:02:55","subject":"公告本公司限制員工權利新股收回減資變更登記完成","clause":"第36款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-04-22 15:02，「公告本公司限制員工權利新股收回減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-04-22-1459-nd69ti","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"14:59:13","subject":"公告本公司董事會決議114年股東常會通過之私募普通股案，於115年股東常會後不繼續辦理","clause":"第14款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-04-22 14:59，「公告本公司董事會決議114年股東常會通過之私募普通股案，於115年股東常會後不繼續辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-04-22-1446-vl81e7","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"14:46:42","subject":"公告本公司115年第1季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-04-22 14:46，「公告本公司115年第1季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-04-22-1432-ps7z81","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"14:32:29","subject":"公告本公司獨立董事辭任功能性委員會職務","clause":"第6款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-04-22 14:32，「公告本公司獨立董事辭任功能性委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-04-22-1431-1em28wc","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-04-22","time":"14:31:51","subject":"本公司獨立董事辭任","clause":"第6款","fact_date":"2026-04-22","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-04-22 14:31，「本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-04-22-0410-16nyp1e","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-04-22","time":"04:10:21","subject":"代重要子公司Belite Bio, Inc公告用於治療斯特格病變新藥LBS-008向美國食品藥物管理局(FDA)啟動新藥查驗登記申請滾動式送件(Rolling Submission of NDA)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-04-22 04:10，「代重要子公司Belite Bio, Inc公告用於治療斯特格病變新藥LBS-008向美國食品藥物管理局(FDA)啟動新藥」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}